Loading clinical trials...
Loading clinical trials...
Cerebellar superficial siderosis (SS) has been recently reported to be present in about 10% of both hereditary (n=50) and sporadic (n=46) cerebral amyloid angiopathy (CAA) patients on 3T MRI using sus...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
NCT05709314 · Cerebral Amyloid Angiopathy
NCT07098650 · Superficial Siderosis
NCT07026994 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
NCT05734378 · Cerebral Amyloid Angiopathy, Small Vessel Cerebrovascular Disease, and more
NCT05499169 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage, and more
CHU de Nîmes
Nîmes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions